Between-trial heterogeneity in ARDS research
Por um escritor misterioso
Descrição
Personalized mechanical ventilation in acute respiratory distress syndrome, Critical Care
Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019 - eClinicalMedicine
Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes, Respiratory Research
Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling - ScienceDirect
Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies
Frontiers Unsuccessful and Successful Clinical Trials in Acute Respiratory Distress Syndrome: Addressing Physiology-Based Gaps
Opportunities for improved clinical trial designs in acute respiratory distress syndrome - The Lancet Respiratory Medicine
Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes, Respiratory Research
Ongoing/planned clinical trials in ARDS
Physiological and clinical variables identify ARDS classes and therapeutic heterogeneity to glucocorticoids: a retrospective study, BMC Pulmonary Medicine
Understanding clinical and biological heterogeneity to advance precision medicine in paediatric acute respiratory distress syndrome - The Lancet Respiratory Medicine
